Our findings strongly suggest the answer is yes. Primes recent real-world study found 63% of high-potency GLP-1 (Wegovy or Zepbound) users who started treatment in Q1 2024 are still taking their medication after a year
( PMID: 28624960 ) Al-Badri MR, Azar ST (2014) Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
It is worth noting that not all patients experience side effects, and individual responses vary considerably
At Eden Medical Clinic, we do not offer this treatment due to its lack of FDA approval and insufficient scientific research supporting its claims
Backup plans: Extra doses, pharmacy contacts, and replacements If your prescription and insurance allow it, bring one extra dose and keep it in the original packaging with the prescription label
Schedule Your Consultation Now "Weight loss has been an all-consuming stressor for much of my life, so to finally watch my body lose weight when I take the right stepssomething that hasnt been happening through other effortsI have a renewed faith in my body, health, and future